$4.82 -0.21 (-4.17%)
2/10/2012 4:00 PM

Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Featured Broker Partners


Advertisement